Bloomberg Roche Holding AG’s bet on fields outside its mainstay market of cancer is starting to pay off as the Swiss drugmaker boosted its forecast for this year. New medicines such as Ocrevus for multiple sclerosis and Hemlibra for hemophilia are driving the increase, the company said in a statement. The world’s biggest maker of cancer treatments also reported sales ...

Bloomberg Ceridian HCM Holding Inc., the software maker backed by Thomas H. Lee Partners, raised $462 million in its initial public offering. The company priced 21 million shares at $22 apiece, above the $19 to $21 price range marketed to investors, according to data compiled by Bloomberg. The IPO gives Ceridian a market value of almost $3 billion, according to ...

Bloomberg Ford Motor Co. is sharpening its knives to cleave another $11.5 billion from spending plans and cut several sedans, including the Fusion and Taurus, from its lineup to more quickly reach an elusive profit target. The automaker expects to save $25.5 billion by 2022, Chief Financial Officer Bob Shanks told reporters as Ford reported first-quarter earnings per share and ...